Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE PHARMACEUTICAL SOLVENT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MARKET APPLICATION COVERAGE GRID
2.7 MULTIVARIATE MODELLING
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTLE ANALYSIS
4.3 CLIMATE CHANGE SCENARIO – EUROPE PHARMACEUTICAL SOLVENT MARKET
4.3.1 ENVIRONMENTAL CONCERNS
4.3.2 INDUSTRY RESPONSE
4.3.3 GOVERNMENT’S ROLE
4.4 PRICING ANALYSIS – EUROPE PHARMACEUTICAL SOLVENT MARKET
4.4.1 RAW MATERIAL COSTS
4.4.2 PURITY AND GRADE
4.4.3 REGULATORY COMPLIANCE COSTS
4.4.4 REGIONAL PRICING VARIABILITY
4.4.5 SUPPLY CHAIN & LOGISTICS
4.4.6 COMPETITIVE LANDSCAPE
4.4.7 FORECASTED PRICING TRENDS (2025–2032)
4.5 PRODUCTION CAPACITY OVERVIEW – EUROPE PHARMACEUTICAL SOLVENT MARKET
4.5.1 KEY PRODUCTION HUBS
4.5.2 CAPACITY UTILIZATION TRENDS
4.5.3 IMPACT OF GREEN CHEMISTRY INITIATIVES
4.5.4 CAPACITY CONSTRAINTS & CHALLENGES
4.6 RAW MATERIAL COVERAGE
4.6.1 IMPORT-EXPORT ANALYSIS
4.6.2 PRODUCTION–CONSUMPTION ANALYSIS
4.7 SUPPLY CHAIN ANALYSIS – EUROPE PHARMACEUTICAL SOLVENT MARKET
4.7.1 OVERVIEW
4.7.2 LOGISTIC COST SCENARIO
4.7.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS
4.8 TARIFFS AND ITS IMPACT ON THE MARKET – EUROPE PHARMACEUTICAL SOLVENT MARKET
4.8.1 DEFINITION AND IMPORTANCE OF TARIFFS IN THE HEALTHCARE SECTOR
4.8.2 GLOBAL VS. REGIONAL TARIFF STRUCTURES
4.8.3 IMPACT OF TARIFFS ON HEALTHCARE COSTS AND ACCESSIBILITY
4.8.4 TARIFF REGULATIONS IN KEY MARKETS
4.8.4.1 MEDICARE/MEDICAID TARIFF POLICIES
4.8.4.2 CMS PRICING MODELS
4.8.4.3 OTHER COUNTRY-SPECIFIC SYSTEMS
4.8.4.4 TARIFFS ON MEDICAL DEVICES & EQUIPMENT
4.8.4.5 IMPORT/EXPORT DUTIES ON MEDICAL EQUIPMENT
4.8.4.6 IMPACT ON PRICING AND AVAILABILITY OF HIGH-END MEDICAL TECHNOLOGY
4.8.5 COST BURDEN ON HOSPITALS AND HEALTHCARE FACILITIES
4.8.6 TARIFF EXEMPTIONS AND INCENTIVES
4.8.7 DUTY-FREE IMPORTS FOR ESSENTIAL MEDICINES AND VACCINES
4.8.8 IMPACT OF TRADE WARS ON THE HEALTHCARE SUPPLY CHAIN
4.8.9 ROLE OF FREE TRADE AGREEMENTS (FTAS) IN REDUCING TARIFFS
4.9 VENDOR SELECTION CRITERIA:
5 REGULATION COVERAGE – EUROPE PHARMACEUTICAL SOLVENT MARKET
5.1 PRODUCT CODES
5.2 CERTIFIED STANDARDS
5.3 SAFETY STANDARDS
5.3.1 MATERIAL HANDLING & STORAGE
5.3.2 TRANSPORT & PRECAUTIONS
5.3.3 HAZARD IDENTIFICATION
6 MARKET OVERVIEW
6.1 DRIVER
6.1.1 INCREASE IN THE MANUFACTURING OF INNOVATIVE GENERIC MEDICATIONS, ESPECIALLY WITHIN EMERGING ECONOMIES
6.1.2 INCREASE IN DEMAND FOR ALCOHOL SOLVENTS FOR MANUFACTURING OF VARIOUS DRUGS.
6.1.3 GROWTH IN PHARMACEUTICAL, AND HEALTHCARE SECTOR ACROSS THE EUROPE
6.1.4 RISE IN ADOPTION OF GREEN MATERIALS AND CHEMICALS FOR DRUG
6.2 RESTRAINT
6.2.1 ADOPTION OF GREEN SOLVENTS POSES OPERATIONAL AND TECHNICAL CHALLENGES
6.2.2 SHORTAGE OF SPECIALIZED WORKFORCE HINDERING SOLVENT PRODUCTION EFFICIENCY
6.3 OPPORTUNITY
6.3.1 EXPANSION OF BIOSIMILARS AND HIGH-POTENCY DRUGS
6.3.2 RISE IN CLINICAL TRIALS AND R&D INVESTMENTS
6.3.3 INCREASING FOCUS ON PERSONALIZED MEDICINE AND ORPHAN DRUGS.
6.4 CHALLENGES
6.4.1 COMPETITION FROM ALTERNATIVE FORMULATION TECHNOLOGIES
6.4.2 HEALTH AND SAFETY CONCERNS REGARDING PHARMACEUTICAL SOLVENTS
7 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 ALCOHOLS
7.2.1 METHANOL
7.2.2 ETHANOL
7.2.3 1-BUTANOL
7.2.4 2-BUTANOL
7.2.5 2-METHOXYETHANOL
7.2.6 3-METHYL-1-PROPANOL
7.2.7 2-METHYL-1-PROPANOL
7.2.8 1-PENTANOL
7.2.9 1-PROPANOL
7.2.10 2-PROPANOL (ISOPROPYL ALCOHOL)
7.2.11 ISOPROPANOL
7.2.12 PROPYLENE GLYCOL
7.2.13 OTHERS
7.3 AROMATIC HYDROCARBONS
7.3.1 TOLUENE
7.3.2 XYLENE
7.3.3 ETHYLBENZENE
7.3.4 OTHERS
7.4 KETONES
7.4.1 ACETONE
7.4.2 CYCLOHEXANONE
7.4.3 METHYL ETHER KETONE
7.4.4 METHYL ETHYL KETONE
7.4.5 METHYL ISOBUTYL KETONE
7.4.6 OTHERS
7.5 ETHERS
7.5.1 DIETHYL ETHER
7.5.2 TETRAHYDROFURAN
7.5.3 METHOXYMETHANE
7.5.4 METHYL TERT-BUTYL ETHER
7.5.5 POLYETHYLENE GLYCOL
7.5.6 ANISOLE
7.5.7 DI-N-PROPYL ETHER
7.5.8 OTHERS
7.6 AMINE
7.6.1 MONOETHANOLAMIDE (MEA)
7.6.2 ANILINE
7.6.3 DIETHANOLAMINE (DEA)
7.6.4 METHYL DIETHANOLAMINE (MDEA)
7.6.5 TRIMETHYLAMINE
7.6.6 OTHERS
7.7 ESTERS
7.7.1 ACETYL ACETATE
7.7.2 ETHYL ACETATE
7.7.3 BUTYL ACETATE
7.7.4 OTHERS
7.8 CHLORINATED SOLVENTS
7.8.1 TRICHLOROETHYLENE (TCE)
7.8.2 DICHLOROMETHANE
7.8.3 PERCHLOROETHYLENE (PCE)
7.8.4 TRICHLOROETHANE (TCA)
7.8.5 CARBON TETRACHLORIDE
7.8.6 OTHERS
7.9 OTHERS
8 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 PHARMACEUTICAL
8.3 RESEARCH LABORATORIES
8.4 CHEMICAL
8.5 OTHERS
9 EUROPE PHARMACEUTICAL SOLVENT MARKET BY COUNTRIES
9.1 EUROPE
9.1.1 SWITZERLAND
9.1.2 ITALY
9.1.3 GERMANY
9.1.4 FRANCE
9.1.5 U.K.
9.1.6 SPAIN
9.1.7 BELGIUM
9.1.8 NETHERLANDS
9.1.9 RUSSIA
9.1.10 TURKEY
9.1.11 LUXEMBURG
9.1.12 REST OF EUROPE
10 EUROPE PHARMACEUTICAL SOLVENT MARKET: COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: EUROPE
11 SWOT ANALYSIS
12 COMPANY PROFILES
12.1 BASF CORPORATION
12.1.1 COMPANY SNAPSHOT
12.1.2 PRODUCT PORTFOLIO
12.1.3 RECENT UPDATES
12.2 SHELL PLC
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 PRODUCT PORTFOLIO
12.2.4 RECENT DEVELOPMENT
12.3 BAYER AG
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 PRODUCT PORTFOLIO
12.3.4 RECENT DEVELOPMENT
12.4 MERCK KGAA
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 PRODUCT PORTFOLIO
12.4.4 RECENT UPDATES
12.5 CLARIANT
12.5.1 COMPANY SNAPSHOT
12.5.2 REVENUE ANALYSIS
12.5.3 PRODUCT PORTFOLIO
12.5.4 RECENT DEVELOPMENT
12.6 ACTYLIS
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT UPDATES
12.7 ADVION INTERCHIM SCIENTIFIC
12.7.1 COMPANY SNAPSHOT
12.7.2 PRODUCT PORTFOLIO
12.7.3 RECENT DEVELOPMENT
12.8 BRASKEM
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENT
12.9 CARL ROTH GMBH + CO. KG
12.9.1 COMPANY SNAPSHOT
12.9.2 PRODUCT PORTFOLIO
12.9.3 RECENT DEVELOPMENT/NEWS
12.1 CHEMCO UK
12.10.1 COMPANY SNAPSHOT
12.10.2 PRODUCT PORTFOLIO
12.10.3 RECENT DEVELOPMENT
12.11 DOW
12.11.1 COMPANY SNAPSHOT
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENT
12.12 DUPONT
12.12.1 COMPANY SNAPSHOT
12.12.2 REVENUE ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENT
12.13 EASTMAN CHEMICAL COMPANY
12.13.1 COMPANY SNAPSHOT
12.13.2 REVENUE ANALYSIS
12.13.3 PRODUCT PORTFOLIO
12.13.4 RECENT DEVELOPMENT
12.14 EXXON MOBIL CORPORATION
12.14.1 COMPANY SNAPSHOT
12.14.2 REVENUE ANALYSIS
12.14.3 PRODUCT PORTFOLIO
12.14.4 RECENT DEVELOPMENT
12.15 LYONDELLBASELL INDUSTRIES HOLDINGS B.V.
12.15.1 COMPANY SNAPSHOT
12.15.2 REVENUE ANALYSIS
12.15.3 PRODUCT PORTFOLIO
12.15.4 RECENT DEVELOPMENT
12.16 MITSUI CHEMICALS, INC.
12.16.1 COMPANY SNAPSHOT
12.16.2 REVENUE ANALYSIS
12.16.3 PRODUCT PORTFOLIO
12.16.4 RECENT DEVELOPMENT
12.17 NOURYON
12.17.1 COMPANY SNAPSHOT
12.17.2 PRODUCT PORTFOLIO
12.17.3 RECENT UPDATES
12.18 PCC GROUP
12.18.1 COMPANY SNAPSHOT
12.18.2 PRODUCT PORTFOLIO
12.18.3 RECENT UPDATES
12.19 SEQENS
12.19.1 COMPANY SNAPSHOT
12.19.2 PRODUCT PORTFOLIO
12.19.3 RECENT DEVELOPMENT
12.2 SK CHEMICALS
12.20.1 COMPANY SNAPSHOT
12.20.2 PRODUCT PORTFOLIO
12.20.3 RECENT DEVELOPMENT
13 QUESTIONNAIRE
14 RELATED REPORTS
List of Table
TABLE 1 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 2 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)
TABLE 3 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)
TABLE 4 EUROPE ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 5 EUROPE AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 6 EUROPE KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 7 EUROPE ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 8 EUROPE AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 9 EUROPE ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 10 EUROPE CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 11 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 12 EUROPE PHARMACEUTICAL SOLVENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 13 SWITZERLAND PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 14 SWITZERLAND PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)
TABLE 15 SWITZERLAND PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)
TABLE 16 SWITZERLAND ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 17 SWITZERLAND AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 18 SWITZERLAND KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 19 SWITZERLAND ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 20 SWITZERLAND AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 21 SWITZERLAND ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 22 SWITZERLAND CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 23 SWITZERLAND PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 24 ITALY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 25 ITALY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)
TABLE 26 ITALY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)
TABLE 27 ITALY ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 28 ITALY AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 29 ITALY KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 30 ITALY ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 31 ITALY AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 32 ITALY ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 33 ITALY CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 34 ITALY PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 35 GERMANY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 36 GERMANY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)
TABLE 37 GERMANY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)
TABLE 38 GERMANY ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 39 GERMANY AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 40 GERMANY KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 41 GERMANY ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 42 GERMANY AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 43 GERMANY ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 44 GERMANY CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 45 GERMANY PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 46 FRANCE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 47 FRANCE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)
TABLE 48 FRANCE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)
TABLE 49 FRANCE ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 50 FRANCE AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 51 FRANCE KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 52 FRANCE ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 53 FRANCE AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 54 FRANCE ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 55 FRANCE CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 56 FRANCE PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 57 U.K. PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 58 U.K. PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)
TABLE 59 U.K. PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)
TABLE 60 U.K. ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 61 U.K. AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 62 U.K. KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 63 U.K. ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 64 U.K. AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 65 U.K. ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 66 U.K. CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 67 U.K. PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 68 SPAIN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 69 SPAIN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)
TABLE 70 SPAIN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)
TABLE 71 SPAIN ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 72 SPAIN AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 73 SPAIN KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 74 SPAIN ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 75 SPAIN AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 76 SPAIN ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 77 SPAIN CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 78 SPAIN PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 79 BELGIUM PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 80 BELGIUM PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)
TABLE 81 BELGIUM PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)
TABLE 82 BELGIUM ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 83 BELGIUM AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 84 BELGIUM KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 85 BELGIUM ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 86 BELGIUM AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 87 BELGIUM ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 88 BELGIUM CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 89 BELGIUM PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 90 NETHERLANDS PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 91 NETHERLANDS PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)
TABLE 92 NETHERLANDS PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)
TABLE 93 NETHERLANDS ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 94 NETHERLANDS AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 95 NETHERLANDS KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 96 NETHERLANDS ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 97 NETHERLANDS AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 98 NETHERLANDS ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 99 NETHERLANDS CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 100 NETHERLANDS PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 101 RUSSIA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 102 RUSSIA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)
TABLE 103 RUSSIA PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)
TABLE 104 RUSSIA ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 105 RUSSIA AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 106 RUSSIA KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 107 RUSSIA ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 108 RUSSIA AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 109 RUSSIA ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 110 RUSSIA CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 111 RUSSIA PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 112 TURKEY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 113 TURKEY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)
TABLE 114 TURKEY PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)
TABLE 115 TURKEY ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 116 TURKEY AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 117 TURKEY KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 118 TURKEY ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 119 TURKEY AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 120 TURKEY ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 121 TURKEY CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 122 TURKEY PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 123 LUXEMBURG PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 124 LUXEMBURG PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)
TABLE 125 LUXEMBURG PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/ METRIC TONS)
TABLE 126 LUXEMBURG ALCOHOLS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 127 LUXEMBURG AROMATIC HYDROCARBONS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 128 LUXEMBURG KETONES IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 129 LUXEMBURG ETHERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 130 LUXEMBURG AMINE IN PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 131 LUXEMBURG ESTERS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 132 LUXEMBURG CHLORINATED SOLVENTS IN PHARMACEUTICAL SOLVENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 133 LUXEMBURG PHARMACEUTICAL SOLVENT MARKET, BY APPLICATION, 2018-2032 (USD THOUSAND)
TABLE 134 REST OF EUROPE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD THOUSAND)
TABLE 135 REST OF EUROPE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (THOUSAND TONS)
TABLE 136 REST EUROPE PHARMACEUTICAL SOLVENT MARKET, BY PRODUCT, 2018-2032 (USD/METRIC TONS)
List of Figure
FIGURE 1 EUROPE PHARMACEUTICAL SOLVENT MARKET: SEGMENTATION
FIGURE 2 EUROPE PHARMACEUTICAL SOLVENT MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE PHARMACEUTICAL SOLVENT MARKET: DROC ANALYSIS
FIGURE 4 EUROPE PHARMACEUTICAL SOLVENT MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE PHARMACEUTICAL SOLVENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE PHARMACEUTICAL SOLVENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE PHARMACEUTICAL SOLVENT MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 EUROPE PHARMACEUTICAL SOLVENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE PHARMACEUTICAL SOLVENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE PHARMACEUTICAL SOLVENT MARKET: SEGMENTATION
FIGURE 11 INCREASE IN THE MANUFACTURING OF INNOVATIVE GENERIC MEDICATIONS, ESPECIALLY WITHIN EMERGING ECONOMIES IS DRIVING THE GROWTH OF THE EUROPE PHARMACEUTICAL SOLVENT MARKET FROM 2025 TO 2032
FIGURE 12 THE ALCOHOLS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE PHARMACEUTICAL SOLVENT MARKET IN 2025 AND 2032
FIGURE 13 EUROPE PHARMACEUTICAL SOLVENT MARKET EXECUTIVE SUMMARY
FIGURE 14 STRATEGIC DECISIONS
FIGURE 15 DROC ANALYSIS
FIGURE 16 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY PRODUCT, 2024
FIGURE 17 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY PRODUCT, 2025 TO 2032 (USD THOUSAND)
FIGURE 18 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY PRODUCT, CAGR (2025- 2032)
FIGURE 19 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 20 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY APPLICATION, 2024
FIGURE 21 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY APPLICATION, 2025 TO 2032 (USD THOUSAND)
FIGURE 22 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY APPLICATION, CAGR (2025- 2032)
FIGURE 23 EUROPE PHARMACEUTICAL SOLVENT MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 24 EUROPE PHARMACEUTICAL SOLVENT MARKET SNAPSHOT
FIGURE 25 EUROPE PHARMACEUTICAL SOLVENT MARKET: COMPANY SHARE 2024 (%)
